Fortis Malar Hospitals
59.81
-1.79(-2.91%)
Market Cap₹112.05 Cr
PE Ratio25.45
Company Performance:
1D-2.91%
1M-5.17%
6M-17.67%
1Y-1.16%
5Y+15.02%
View Company Insightsright
More news about Fortis Malar Hospitals
16Oct 25
IHH Healthcare Announces Open Offer Tendering Period for Fortis and Malar Hospitals Shares
IHH Healthcare Berhad has initiated open offers to acquire shares in Fortis Healthcare Limited and Fortis Malar Hospitals. The tendering period is set for October 20-November 4, 2025. For Fortis Healthcare, the offer is for up to 197,025,660 shares (26.10% of expanded voting share capital), while for Fortis Malar, it's for up to 4,894,308 shares (26.11% of voting share capital). Northern TK Venture Pte Ltd, an indirect wholly-owned subsidiary of IHH, is the acquiring entity. The Committees of Independent Directors of both companies published their recommendations on October 16, 2025. The transaction also includes a subscription of 235,294,117 new equity shares in Fortis Healthcare through preferential allotment to Northern TK Venture Pte Ltd.
03Oct 25
SEBI Greenlights IHH Healthcare's Open Offer for Fortis Healthcare and Fortis Malar Hospitals
SEBI has approved IHH Healthcare Berhad's open offers for Fortis Healthcare and Fortis Malar Hospitals. The transaction includes a preferential allotment of 235,294,117 new Fortis shares to IHH's subsidiary, an open offer for up to 26.10% of Fortis Healthcare's expanded voting capital, and another for 26.11% of Fortis Malar Hospitals' voting capital. This approval, communicated on October 1, allows IHH Healthcare to proceed with its strategic investment in the Indian healthcare market. The companies have made necessary disclosures to their respective stock exchanges.
06Sept 25
Fortis Malar Hospitals Reports Narrowed Q3 FY2023 Loss of Rs 1.17 Crore
Fortis Malar Hospitals Limited reported a standalone loss before tax of Rs 1.17 crore for Q3 FY2023, a 56.83% improvement from the Rs 2.71 crore loss in Q3 FY2022. Revenue from operations increased by 7.09% to Rs 21.90 crore. Total expenses were Rs 24.57 crore, with major components including professional charges to doctors, employee benefits, and purchase of medical consumables. The company's EPS was negative at Rs 0.62. Fortis Malar is dealing with a legal matter regarding hospital building regularization, with related expenses to be borne by Fortis Health Management Limited.
04Aug 25
Fortis Malar Hospitals Reports Profit of Rs 417.65 Crore in Q1 After Business Sale
Fortis Malar Hospitals Limited reported a profit after tax of Rs 417.65 crore for the quarter ended June 30, primarily due to other income of Rs 460.72 crore following the sale of its business operations. The company has no current business operations but maintains a strong financial position with cash and cash equivalents of approximately Rs 3,232.39 crore. Management is evaluating corporate restructuring options for future action. The company's subsidiary, Malar Stars Medicare Limited, converted to a Section 8 Company. Fortis Malar has filed appeals against various tax demands and reversed a provision of Rs 408.20 crore towards earlier minimum wages payable.
Fortis Malar Hospitals
59.81
-1.79
(-2.91%)
1 Year Returns:-1.16%
Industry Peers
Max Healthcare Institute
1,081.40
(+0.58%)
Apollo Hospitals
7,172.00
(+1.39%)
Fortis Healthcare
902.70
(+0.12%)
Narayana Hrudayalaya
1,876.20
(-0.02%)
Global Health
1,191.20
(+0.27%)
Aster DM Healthcare
597.20
(-0.03%)